80565-42-0 Usage
Description
(3-methyl-5-methyl-4-isoxazolyl)dimethylindoleglyoxylamide is a complex chemical compound that is a derivative of dimethylindoleglyoxylamide, featuring a 3-methyl-5-methyl-4-isoxazolyl group. (3-methyl-5-methyl-4-isoxazolyl)dimethylindoleglyoxylamide may possess potential biological or pharmacological activity due to the presence of isoxazolyl and indoleglyoxylamide moieties, which are commonly found in pharmaceutical compounds.
Uses
Further research is required to determine the specific properties and potential uses of (3-methyl-5-methyl-4-isoxazolyl)dimethylindoleglyoxylamide. Its potential applications may span various industries, including pharmaceuticals, depending on its biological activity and pharmacological profile.
Check Digit Verification of cas no
The CAS Registry Mumber 80565-42-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,5,6 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 80565-42:
(7*8)+(6*0)+(5*5)+(4*6)+(3*5)+(2*4)+(1*2)=130
130 % 10 = 0
So 80565-42-0 is a valid CAS Registry Number.
InChI:InChI=1/C18H19N3O3/c1-5-12-14(10(2)24-20-12)16-15(17(22)18(23)21(3)4)11-8-6-7-9-13(11)19-16/h6-9,19H,5H2,1-4H3
80565-42-0Relevant articles and documents
Isoxazolyl indolamines
-
, (2008/06/13)
This disclosure describes compounds of the formula STR1 where R1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms or lower alkoxy having 1 to 4 carbon atoms, and R2 represents hydroxy, and R3 and R4 each independently represent lower alkyl as defined above, or R3 and R4 together with N represent STR2 wherein n is 1, 2, or 3, and R5 and R6 each independently represent hydrogen or lower alkyl as defined above, and R7 represents lower alkyl as defined above, or a pharmaceutically acceptable acid addition salt thereof, which are useful as anti-diabetic agents, in particular as hypoglycemic agents and inhibiting or impeding postprandial hyperglycemia.
